Kristin Brooks01.10.14
Chris Kilbee has been appointed group director of UBM Pharma Portfolio CPhI, part of UBM Live. Mr. Kilbee will be responsible for the strategic development and delivery of event brands CPhI, ICSE, Inno-Pack and P-MEC, held in Europe, China, India, Japan, Russia, Turkey, South America and South-East Asia, and digital solutions including CPhI Online and CPhI Pharma Evolution.
Mr. Kilbee is an experienced business leader who has worked across a number of different areas at UBM, most recently running a media and events business based in London. Chris has overseen the launch of CPhI Istanbul, a new event starting in 2014, and the completion of the company’s first Annual Industry Report.
Mr. Kilbee said, “I am delighted to be taking on this position and overseeing the Pharma portfolio at UBM Live. It is our vision to widen CPhI’s pharma portfolio across new and diverse geographies and platforms where we see opportunities emerging, delivering new services that help to connect the pharma community.”
Mr. Kilbee is an experienced business leader who has worked across a number of different areas at UBM, most recently running a media and events business based in London. Chris has overseen the launch of CPhI Istanbul, a new event starting in 2014, and the completion of the company’s first Annual Industry Report.
Mr. Kilbee said, “I am delighted to be taking on this position and overseeing the Pharma portfolio at UBM Live. It is our vision to widen CPhI’s pharma portfolio across new and diverse geographies and platforms where we see opportunities emerging, delivering new services that help to connect the pharma community.”